What are the treatment options for settling symptoms in Parkinson's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Settling Symptoms in Parkinson's Disease

Levodopa/carbidopa is the most effective medication for treating motor symptoms in Parkinson's disease and should be the first-line treatment for most patients. 1, 2, 3

First-Line Pharmacological Treatment

  • Levodopa is the metabolic precursor of dopamine that crosses the blood-brain barrier and is converted to dopamine in the brain, which is the mechanism whereby it relieves symptoms of Parkinson's disease 4
  • For optimal absorption, levodopa should be taken at least 30 minutes before meals to avoid interactions with dietary proteins that can reduce efficacy 1, 2
  • Carbidopa inhibits decarboxylation of peripheral levodopa, making more levodopa available for transport to the brain and reducing side effects like nausea and vomiting 4

Optimizing Levodopa Administration

  • For patients experiencing motor fluctuations on levodopa, implementing a protein redistribution diet (low-protein breakfast and lunch, with normal protein intake at dinner) can improve motor function 1, 2
  • Monitor for common side effects of levodopa including nausea, vomiting, abdominal pain, dyspepsia, constipation, weight decrease, dry mouth, and anorexia 2, 4
  • Levodopa may cause hyperhomocysteinemia, especially in older patients and those with long-standing disease, requiring vitamin B supplementation 2

Advanced Therapies for Medication-Resistant Symptoms

  • Both subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) are effective for motor symptom control when medications are no longer providing adequate relief 1, 2
  • If medication reduction is a primary goal, STN DBS is preferred 1
  • If there are concerns about cognitive decline or depression, GPi DBS may be more appropriate 1, 3
  • Magnetic resonance-guided focused ultrasound (MRgFUS) is an emerging incisionless option for medication-resistant tremor 1
  • For continuous dopamine delivery, duodenal infusion of levodopa/carbidopa can be considered for advanced disease with motor fluctuations 5, 6

Management of Sleep Disturbances

  • For REM sleep behavior disorder (RBD) in Parkinson's disease:
    • Melatonin (starting at 3 mg and increasing by 3-mg increments to 15 mg) is recommended, especially for older patients, as it is only mildly sedating 2, 3
    • Clonazepam is commonly used but has side effects including morning sedation, gait imbalance/falls, depression, and cognitive disturbances 2, 3
    • Rivastigmine may be appropriate for patients with RBD and cognitive impairment refractory to other treatments 2

Nutritional Management

  • Regular monitoring of nutritional and vitamin status is recommended, with particular attention to changes in body weight and the need for vitamin D, folic acid, and vitamin B12 supplementation 2
  • Patients with constipation may benefit from fermented milk with probiotics and prebiotic fiber, in addition to increased water and fiber intake 2
  • For tube-fed patients on oral levodopa, interrupting enteral nutrition for at least 1 hour before and 30-40 minutes after medication administration is recommended 2

Common Pitfalls and Caveats

  • Avoid strict low-protein diets as they may lead to nutritional deficiencies without evidence-based benefits 1, 2, 3
  • Increasing doses of levodopa over time are associated with a higher risk for malnutrition, requiring careful monitoring 1, 2, 3
  • Patients taking levodopa or dopamine agonists have reported suddenly falling asleep without prior warning while engaged in activities of daily living, including driving 4
  • Motor complications like dyskinesias may occur at lower dosages and sooner with levodopa than with other treatments, requiring careful dose adjustment 4, 7
  • Sporadic cases of neuroleptic malignant syndrome have been reported with dose reductions or withdrawal of antiparkinsonian agents, requiring careful observation during dosage changes 4

References

Guideline

Treatment of Tremors in Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Regimen for Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Newly Diagnosed Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.